Skip to content
Back to search

NCT07132034Recruiting

Stress Reduction Through Acupuncture

Summary

This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.

Inclusion criteria

• Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial • Prior cancer is allowed • Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed • Concomitant participation in an experimental therapeutic drug trial is allowed • Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed • Use of other complementary methods (including mistletoe) is allowed.

Exclusion criteria

• Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study • Severe physical or psychiatric comorbidity that prevents a patient from participating in the study • Patients incapable of giving consent • Pregnancy

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
No phase (N/A)
Study type
Interventional
Countries
Switzerland
Sponsor
Isabell Xiang Ge(Other)
Protocol no.
2025-01072;bb21HeinzelmannSch3
Conditions
Acupuncture, Breast Cancer, Survivorship
Interventions
Procedure, Other

Treatments studied

  • Acupuncture
  • Standard supportive care

Collaborators

Swiss GO Trial Group

Locations · 2

  • Basel, SwitzerlandUniversity Hospital BaselRecruiting at this site
  • Thun, SwitzerlandOnkologie- & Hämatologiezentrums, Spital STS AG ThunRecruiting at this site

In total, worldwide, 2 of the 3 sites listed in the registry are recruiting; the other one is not currently recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: July 9, 2026).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

Other identifiers

  • 2025 · NIH grant

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.